Drug intelligence / Profile preview

Qidan Yufeng Capsule

Development stage: Preclinical
Lead developer: Modern Chinese Medicine Group
Administration: Oral

Overview

Qidan Yufeng Capsule (耆丹御风胶囊) is a traditional Chinese medicine (TCM) herbal formulation developed by Modern Chinese Medicine Group in collaboration with Heilongjiang University of Chinese Medicine. Intended for the prevention of stroke and the treatment of cerebrovascular diseases, the drug is administered as an oral capsule. It is part of the company's research and development focus on qi-blood tonification and cardiovascular health. Development of this candidate began in 2019, and it is currently in the preclinical stage. As a traditional herbal product, it functions through the synergistic effects of multiple botanical ingredients rather than a single defined molecular mechanism.

Other names: 耆丹御风胶囊Stroke Prevention Capsule

Beyond the preview

Go deeper on Qidan Yufeng Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qidan Yufeng Capsule.

Explore the full profile